88 results on '"Zeng, Qing-Lei"'
Search Results
52. SAT-463 - A diagnostic non-invasive model for liver advanced fibrosis and cirrhosis in chronic hepatitis B (CHB) concurrent with non-alcoholic fatty liver disease (NAFLD) based on machine learning (ML)
53. THU-471 - Diabetes mellitus (DM) is the strongest risk factor of significant inflammation or fibrosis in chronic hepatitis B (CHB) combined with non-alcoholic fatty liver disease (NAFLD)
54. Frequency of circulating CD4+CXCR5+TFH cells are associated with disease severity and treatment outcome in primary biliary cirrhosis patients: 2048
55. Protective role of Vδ2 γδT cells in patients with chronic hepatitis B through regulating function of Th17 cells: 1853
56. Reply to Rabelo-da-Ponte et al
57. Dynamic changes of liver function parameters in patients with coronavirus disease 2019: A multicenter, retrospective study
58. Clinical course and treatment efficacy of COVID‐19 near Hubei Province, China: A multicentre, retrospective study
59. Short-term Peginterferon-Induced High Functional Cure Rate in Inactive Chronic Hepatitis B Virus Carriers With Low Surface Antigen Levels
60. Response to Malkovsky
61. Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019
62. p65/miR‐23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma
63. IL-17A-mediated ERK1/2/p65 signaling pathway is associated with cell apoptosis after non-alcoholic steatohepatitis
64. p65/miR‐23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma.
65. MiR‐19a Affects Hepatocyte Autophagy via Regulating lncRNA NBR2 and AMPK/PPARα in D‐GalN/Lipopolysaccharide‐Stimulated Hepatocytes
66. Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study
67. Clinical Model for Predicting Hepatocellular Carcinomas in Patients with Post-Sustained Virologic Responses of Chronic Hepatitis C: A Case Control Study
68. Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: Too alarming?
69. IL‐17A‐mediated ERK1/2/p65 signaling pathway is associated with cell apoptosis after non‐alcoholic steatohepatitis.
70. Worsening jaundice induced by biliary drainage
71. Prevalence of Hepatitis C Virus and Hepatitis B Virus Infections in Patients Infected with HIV Through Blood Donation or Transfusion in China
72. MiR-19a Affects Hepatocyte Autophagy via Regulating lncRNA NBR2 and AMPK/PPARα in D-GalN/Lipopolysaccharide-Stimulated Hepatocytes.
73. Myeloid-Derived Suppressor Cells Are Associated with Viral Persistence and Downregulation of TCR ζ Chain Expression on CD8+ T Cells in Chronic Hepatitis C Patients
74. Increased myeloid-derived suppressor cells correlate with viral persistence in patients with chronic hepatitis C
75. Risk factors for liver-related mortality in chronic hepatitis C patients: A deceased case-living control study
76. Interleukin‐21 mediates hepatitis B virus‐associated liver cirrhosis by activating hepatic stellate cells
77. Upregulation of OX40 ligand on monocytes contributes to early virological control in patients with chronic hepatitis C
78. Sofosbuvir and ABT-450: Terminator of hepatitis C virus?
79. Age versus clinical virological characteristics in chronic hepatitis B virus infection
80. Spontaneous HBV YMDD motif mutations in patients with familially clustered chronic HBV infection
81. Advances in research on natural YMDD mutations in the hepatitis B virus DNA polymerase in patients with chronic hepatitis B
82. “Fatty” or “steatotic”: position statement from a linguistic perspective by the Chinese-speaking community
83. Curing of chronic hepatitis C combined with coronavirus disease 2019 in a couple over 85 years old: a case series study.
84. Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China.
85. Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306).
86. Sex disparities of the effect of the COVID-19 pandemic on mortality among patients living with tuberculosis in the United States.
87. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.
88. [Fluctuating characteristics of HBsAg quantification and immune system in patients with chronic hepatitis B].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.